⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17124636 | 1.00 | — | — | |
| SCHEMBL16229740 | 1.00 | — | — | |
| SCHEMBL10289741 | 1.00 | — | — | |
| SCHEMBL13700605 | 1.00 | — | — | |
| SCHEMBL765488 | 1.00 | — | — | |
| SCHEMBL2288017 | 1.00 | — | — | |
| SCHEMBL16995166 | 0.94 | — | — | |
| SCHEMBL12127053 | 0.94 | — | — | |
| SCHEMBL11967081 | 0.94 | — | — | |
| SCHEMBL3038801 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265075-A1 | 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS | AJAX THERAPEUTICS, INC. | 2023-08-24 | — | — | US | disclosed |